Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
March 22, 2019 at 12:38 am IST
Share
Sunmax Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was TWD 304.068 million compared to TWD 190.128 million a year ago. Operating income was TWD 62.796 million compared to TWD 13.272 million a year ago. Net income was TWD 74.657 million compared to TWD 16.535 million a year ago. Basic earnings per share was TWD 1.38 compared to TWD 0.31 a year ago.
SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.
SUNMAX BIOTECHNOLOGY CO., LTD. 
